BASL Partners

Thank you to all our Partner organisations

About AstraZeneca 

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. AstraZeneca operates in over 100 countries and its medicines are used by millions of patients worldwide.

With a proud 100-year heritage in advancing UK science, today AstraZeneca is the UK’s leading biopharmaceutical company. The company is based in five different locations across the UK, with its global headquarters in Cambridge. In the UK, around 8,700 employees work in research and development, manufacturing, supply, sales, and marketing. We supply around 36 different medicines to the NHS.  

For more information, please visit www.astrazeneca.co.uk and follow us on Twitter @AstraZenecaUK .

Ipsen U.K. and Ireland is a core part of Ipsen’s global biopharmaceutical business and is driven by the belief that patients don’t have time to wait. We have a biotech mindset coupled with pharmaceutical capabilities and have invested in a robust business presence that spans the early stages of research and development (R&D) through to in-house manufacturing in Wrexham, Wales and Dublin, Ireland, so we can effectively deliver on our promise to U.K. and Irish patients. As part of this investment, we employ over 1,000 people across three sites, representing about 17% of our global workforce, of which over 300 are based in London, home to one of our three Global Hubs alongside Paris, France and Cambridge in the U.S.

At Ipsen, we focus on ensuring innovative solutions reach the people that need it most in oncology, rare disease and neuroscience. We push ourselves to address the most complex and difficult issues facing people’s health to deliver better outcomes. This purpose driven approach ensures we deliver real impact, in a sustainable way, for patients and society. Our licensed medicines and R&D are all focused on improving quality of life and relieving suffering, hoping to bring real value to the healthcare community along every step of the treatment pathway.